Trial intelligence / Profile preview

Memantine for Cognitive Abilities in Young Adults with Down Syndrome

NCT01112683Phase 4Completed

Sponsor
University of Colorado Denver
Start
Jul 2008
Primary completion
Jul 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of memantine in Down syndrome, sponsored by University of Colorado Denver. Started Jul 2008; status: completed.

02

Drugs

memantine
03

Conditions

Down syndrome

Beyond the preview

Go deeper on NCT01112683.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01112683.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call